Factors associated with health-related quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation: a cross-sectional prevalence study

References

• Jung K, Won Y, Oh C, et al. Prediction of cancer incidence and mortality in Korea, 2017. Cancer Res Treat. 2017;49(2):306–312.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA: A Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Jegerlehner S, Bulliard J, Aujesky D, et al. Overdiagnosis and overtreatment of thyroid cancer: a population-based temporal trend study. Plos One. 2017;12(6):e179387.
   Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Jeon M, Kim W, Kwon H, et al. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma. Eur J Endocrinol. 2017;177(1):25–31.
   PubMed Web of Science ®Google Scholar
• Gartland R, Lubitz C. Impact of extent of surgery on tumor recurrence and survival for papillary thyroid cancer patients. Ann Surg Oncol. 2018;25(9):2520–2525.
   PubMed Web of Science ®Google Scholar
• Dobrinja C, Pastoricchio M, Troian M, et al. Partial thyroidectomy for papillary thyroid microcarcinoma: is completion total thyroidectomy indicated? Int J Surg. 2017;41(5):S34–S39.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Laganà D, Mangini M, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008;6(1):S65–S69.
   PubMedGoogle Scholar
• Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244(2):296–304.
   PubMed Web of Science ®Google Scholar
• Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21(8):917–920.
   PubMed Web of Science ®Google Scholar
• Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperther. 2019;36(1):375–381.
   Web of Science ®Google Scholar
• Mauri G, Sconfienza LM. Image-guided thermal ablation might be a way to compensate for image deriving cancer overdiagnosis. Int J Hyperthermia. 2017;33(4):489–490.
   PubMed Web of Science ®Google Scholar
• Lee D, Lee J, Kang T, et al. Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study. Radiology. 2018;286(1):338–349.
   PubMed Web of Science ®Google Scholar
• Seror O, N’Kontchou G, Nault J-C, et al. Hepatocellular carcinoma within milan criteria: no-touch multibipolar radiofrequency ablation for treatment-long-term results. Radiology. 2016;280(2):611–621.
   PubMed Web of Science ®Google Scholar
• Lee G, You J, Kim H, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Lim H, Lee J, Ha E, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23(4):1044–1049.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell J, et al. Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up. Thyroid. 2020;30(3):408–418.
   PubMed Web of Science ®Google Scholar
• Engel GL. The need for a new medical model: a challenge for biomedicine. Psychodyn Psychiatry. 2012;40(3):377–396.
   PubMedGoogle Scholar
• Makai P, Brouwer W, Koopmanschap M, et al. Quality of life instruments for economic evaluations in health and social care for older people: a systematic review. Soc Sci Med. 2014;102(2):83–93.
   PubMed Web of Science ®Google Scholar
• Group W, Study protocol for the World Health Organization Project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res. 1993;2(2):153–159.
   PubMed Web of Science ®Google Scholar
• Lan Y, Luo Y, Zhang M, et al. Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study. Front Endocrinol. 2020;11(5):249.
   PubMed Web of Science ®Google Scholar
• Jeong W, Baek J, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–1250.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
   PubMed Web of Science ®Google Scholar
• Liu J, Gao J, Tang Y, et al. Reliability and validity of Chinese version of Thyroid Cancer-specific Quality of Life (THYCA-QoL) questionnaire. Tumor. 2019;39(03):178–187.
   Google Scholar
• Husson O, Haak HR, Mols F, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol. 2013;52(2):447–454.
   PubMed Web of Science ®Google Scholar
• Husson O, Haak HR, Buffart LM, et al. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based profiles registry. Acta Oncol. 2013;52(2):249–258.
   PubMed Web of Science ®Google Scholar
• Koch L, Jansen L, Herrmann A, et al. Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study. Acta Oncol. 2013;52(6):1119–1128.
   PubMed Web of Science ®Google Scholar
• Mehnert A, Berg P, Henrich G, et al. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273–1280.
   PubMed Web of Science ®Google Scholar
• Thewes B, Butow P, Bell M, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20(11):2651–2659.
   PubMed Web of Science ®Google Scholar
• Huang JK, Ma L, Song WH, et al. Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma. Onco Targets Ther. 2016;9(7):4053–4059.
   PubMed Web of Science ®Google Scholar
• Promberger RMD, Hermann MMD, Pallikunnel SJMD, et al. Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto’s thyroiditis. Am J Surg. 2014;207(6):974–979.
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Lu F, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep. 2016;6(1):37838.
   PubMed Web of Science ®Google Scholar
• Wang R, Wu C, Zhao Y, et al. Health related quality of life measured by SF-36: a population-based study in Shanghai, China. Bmc Public Health. 2008;8(1):292.
   PubMed Web of Science ®Google Scholar
• Lubitz CC, De Gregorio L, Fingeret AL, et al. Measurement and variation in estimation of quality of life effects of patients undergoing treatment for papillary thyroid carcinoma. Thyroid. 2017;27(2):197–206.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
   PubMed Web of Science ®Google Scholar
• Aschebrook-Kilfoy B, James B, Nagar S, et al. Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American Thyroid Cancer Survivorship Study. Thyroid. 2015;25(12):1313–1321.
   PubMed Web of Science ®Google Scholar
• Wang T, Jiang M, Ren Y, et al. Health-related quality of life of community thyroid cancer survivors in Hangzhou, China. Thyroid. 2018;28(8):1013–1023.
   PubMed Web of Science ®Google Scholar
• Crevenna R, Zettinig G, Keilani M, et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Supp Care Cancer: Official J Multinational Assoc Supp Care Cancer. 2003;11(9):597–603.
   PubMed Web of Science ®Google Scholar
• Bresner L, Banach R, Rodin G, et al. Cancer-related worry in Canadian thyroid cancer survivors. The J Clin Endocrinol Metabol. 2015;100(3):977–985.
   PubMed Web of Science ®Google Scholar
• Hedman C, Djarv T, Strang P, et al. Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden. Acta Oncol. 2016;55(3):365–369.
   PubMed Web of Science ®Google Scholar
• Sengoku M, Murata H, Kawahara T, et al. Does daily Naikan therapy maintain the efficacy of intensive Naikan therapy against depression? Psychiatry Clin Neurosci. 2010;64(1):44–51.
   PubMed Web of Science ®Google Scholar
• Tashiro S, Hosoda S, Kawahara R. [Naikan therapy for prolonged depression: psychological changes and long-term efficacy of intensive Naikan therapy]. Seishin Shinkeigaku Zasshi. 2004;106(4):431–457. In Japanese.
   PubMedGoogle Scholar
• Crombez P, Bron D, Michiels S. Multicultural approaches of cancer pain. Curr Opin Oncol. 2019;31(4):268–274.
   PubMed Web of Science ®Google Scholar